Breakthrough in Nanotechnology: Researchers Develop Promising Nanocarriers for Cancer Therapy
A team of researchers at Manipal University has made a significant breakthrough in the development of nanocarriers for cancer therapy. They have synthesized and evaluated polymer-functionalized molybdenum disulfide (MoS) nanoplatforms with distinct morphologies, including three-dimensional (3D) nanoflowers and two-dimensional (2D) nanorods. The researchers' innovative approach has led to the creation of a nanoplatform with enhanced photothermal properties, which shows great potential for targeted drug delivery.
Key Takeaways:
- The researchers synthesized MoS nanoplatforms with distinct morphologies, including 3D nanoflowers and 2D nanorods, tailored for targeted drug delivery applications.
- The MoS nanostructures were functionalized with polyethylene glycol (PEG) and polyethyleneimine (PEI), which enhanced their photothermal properties.
- The researchers evaluated the photothermal properties of the nanoplatforms under 808 nm NIR laser irradiation, with the 3D nanoflowers demonstrating a photothermal conversion efficiency of 46.86%.
- The nanoplatforms showed significant improvement in temperature elevation for drug delivery, with the 3D nanoflowers demonstrating a 4.3°C increase in temperature.
- The researchers concluded that the 3D nanoflowers are a promising candidate for photothermal and photoacoustic imaging-guided drug delivery.
Statistics:
- 46.86%: The photothermal conversion efficiency of the 3D nanoflowers.
- 19.94%: The photothermal conversion efficiency of the 2D nanorods.
- 4.3°C: The increase in temperature elevation for the 3D nanoflowers.
- 10.2°C: The initial temperature elevation for the 2D nanorods.
Sources:
- Morphology-driven photothermal performance of polymer-functionalized mos nanoplatforms for targeted therapeutic applications. Scientific Reports, 2025;15(1):26028.
- Manipal University Reports Findings in Nanoplatforms (Morphology-driven photothermal performance of polymer-functionalized mos nanoplatforms for targeted therapeutic applications). Nanotechnology Weekly. July 28, 2025; p 555.